Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Shares Jump 9.6 Percent After Firm Replaces CEO; Company Cuts 05 Outlook and Delays Earnings

NEW YORK, March 9 (GenomeWeb News) - Shares of Orchid Technologies rallied today on news that the company has replaced its CEO but despite news that Orchid has cut its 2005 revenue forecast and has delayed its earnings release.

 

Orchid was up 9.58 percent, or $.59, at $6.75 in afternoon trade after the company this morning said it fired CEO Paul Kelly and appointed Thomas Bologna to take his place on April 3, or until the company files its 2005 earnings report, according to documents filed today with the US Securities and Exchange Commission. The shares had been declining steadily since mid-January.

 

In terms of the fourth-quarter earnings, Orchid said they will be late this year due to a delay in completing its 2005 due to a delay in the completion of the audit of its 2005 financial statements. The company plans to release the results on March 30.

 

Orchid today cut its 2005 total revenue forecast to between $61 million and $62 million from about $64 million, primarily due to lower-than-expected production capacity in its Dallas facility.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.